Related Experiment Video
Updated: May 17, 2026
11:12
Controlling Parkinson's Disease With Adaptive Deep Brain Stimulation
Published on: July 16, 2014
Update on deep brain stimulation for Parkinson's disease.
1Department of Neurosurgery, University of Minnesota, Minneapolis, MN 55455, USA.
Journal of Neurosurgical Sciences
|November 1, 2012
Summary
Deep brain stimulation (DBS) is a key Parkinson's disease (PD) treatment, but requires precise targeting and carries surgical risks. Ongoing advancements aim for safer, more effective DBS therapies.
Area of Science:
- Neurosurgery
- Neurology
- Biomedical Engineering
Background:
- Deep brain stimulation (DBS) has transitioned from experimental to a primary treatment for Parkinson's disease (PD).
- While effective for selected patients, DBS involves surgical risks and challenges, with mechanisms not fully elucidated.
- The growing patient population highlights the need for improved surgical precision and understanding of deep brain structures.
Purpose of the Study:
- To review the evolution and current status of DBS for Parkinson's disease.
- To discuss the critical aspects of target identification and electrical current delivery in DBS surgery.
- To explore future directions and technological advancements in DBS therapy.
Main Methods:
- Review of existing literature on DBS for Parkinson's disease.
- Analysis of surgical strategies and safety considerations.
- Discussion of emerging technologies in DBS devices and imaging.
Main Results:
- DBS is an established, effective treatment for Parkinson's disease in carefully selected patients.
- Surgical precision in target identification and stimulation delivery remains paramount.
- Continuous improvements in surgical techniques and technology are addressing safety concerns.
Conclusions:
- DBS surgery for Parkinson's disease necessitates precise targeting and delivery of electrical stimulation.
- Advancements in biomedical engineering and imaging are enhancing DBS device sophistication and resolution.
- Future progress in understanding neurophysiology and pathology, informed by DBS experience, will drive the field forward.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...